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The protein calexcitin was originally identiﬁed in molluscan photoreceptor
neurons as a 20 kDa molecule which was up-regulated and phosphorylated
following a Pavlovian conditioning protocol. Subsequent studies showed that
calexcitin regulates the voltage-dependent potassium channel and the calcium-
dependent potassium channel as well as causing the release of calcium ions from
the endoplasmic reticulum (ER) by binding to the ryanodine receptor. A crystal
structure of calexcitin from the squid Loligo pealei showed that the fold is
similar to that of another signalling protein, calmodulin, the N- and C-terminal
domains of which are known to separate upon calcium binding, allowing
interactions with the target protein. Phosphorylation of calexcitin causes it to
translocate to the cell membrane, where its effects on membrane excitability are
exerted and, accordingly, L. pealei calexcitin contains two protein kinase C
phosphorylation sites (Thr61 and Thr188). Thr-to-Asp mutations which mimic
phosphorylation of the protein were introduced and crystal structures of the
corresponding single and double mutants were determined, which suggest that
the C-terminal phosphorylation site (Thr188) exerts the greatest effects on
the protein structure. Extensive NMR studies were also conducted, which
demonstrate that the wild-type protein predominantly adopts a more open
conformation in solution than the crystallographic studies have indicated and,
accordingly, normal-mode dynamic simulations suggest that it has considerably
greater capacity for ﬂexible motion than the X-ray studies had suggested. Like
calmodulin, calexcitin consists of four EF-hand motifs, although only the ﬁrst
three EF-hands of calexcitin are involved in binding calcium ions; the C-terminal
EF-hand lacks the appropriate amino acids. Hence, calexcitin possesses two
functional EF-hands in close proximity in its N-terminal domain and one
functional calcium site in its C-terminal domain. There is evidence that the
protein has two markedly different afﬁnities for calcium ions, the weaker of
which is most likely to be associated with binding of calcium ions to the protein
during neuronal excitation. In the current study, site-directed mutagenesis has
been used to abolish each of the three calcium-binding sites of calexcitin, and
these experiments suggest that it is the single calcium-binding site in the
C-terminal domain of the protein which is likely to have a sensory role in the
neuron.
1. Introduction
The protein calexcitin was originally identiﬁed in the photo-
receptor neurons of the marine snail Hermissenda crassicornis
as a 20 kDa cytosolic protein that became up-regulated
and phosphorylated following a Pavlovian training protocol
(Nelson et al., 1990). Hermissenda are normally attracted
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towards light but are repelled by movement, which causes foot
retraction. The snails become conditioned to retract upon
exposure to light (normally an attractive stimulus) if they are
simultaneously exposed to both light and movement (e.g. on
an illuminated turntable). The up-regulation of calexcitin was
correlated with exposure to both light and movement and
not with each separate stimulus alone. Electrophysiological
studies involving micro-injection of the puriﬁed calexcitin
protein into Hermissenda photoreceptors showed that it
regulated the voltage-dependent potassium channel and the
calcium-dependent potassium channel and was capable of
reproducing the electrophysiological effects of learning in
neurons. The protein was found to bind calcium and there is
evidence that it has GTPase activity (Alkon & Nelson, 1990;
Nelson et al., 1994).
Calexcitin was ﬁrst isolated from the optic lobe of the long-
ﬁnned squid Loligo pealei (Nelson et al., 1996). It has been
shown that the protein kinase C (PKC)-dependent phos-
phorylation of calexcitin causes it to translocate to the cell
membrane, where its effects on membrane excitability are
exerted (Nelson & Alkon, 1995). Accordingly, L. pealei
calexcitin contains two PKC phosphorylation consensus
sequences and is a good substrate for PKC in vitro (Nelson &
Alkon, 1995; Gombos et al., 2001). In neuronal cells, the
activation of PKC or an increase in intracellular Ca2+ can
cause long-term inhibition of K+ currents and it is possible that
calexcitin is involved in these processes. Calexcitin causes the
release of calcium ions from the endoplasmic reticulum (ER)
by binding to and activating ryanodine receptors (Cavallaro
et al., 1997), which form one of the main channels for Ca2+
release from the ER. Calexcitin has been shown to co-purify
with squid ryanodine receptors and the interaction between
these two proteins is calcium-dependent (Nelson et al., 1999).
Phosphorylation of calexcitin by PKC was found to inhibit the
interaction with the ryanodine receptor.
Cloning and sequencing of squid calexcitin cDNA showed
that the protein consists of 191 amino acids and has sequence
similarity to several sarcoplasmic calcium-binding proteins
(SCPs; Nelson et al., 1996). There are three Ca2+-binding sites
in calexcitin, and titration studies have indicated that the
protein has two apparent afﬁnities for calcium, the higher
of which has a Kd of 40 nM. This must be owing to tight
calcium-binding sites which will be occupied even when the
neuron is at resting potential (Ca2+ concentation in the
nanomolar to 0.1 mM range; Ascoli et al., 1997). The protein
has another measurable calcium afﬁnity, referred to as the
regulatory site or sensor site, with aKd that has been estimated
at just below 1 mM and this is in the concentration range for
bulk calcium during neuronal activation.
The evidence that calexcitin is a GTPase (Nelson et al.,
1996) would make this a remarkable, and possibly unique,
protein with dual functions both as a calcium sensor and a G
protein. Whilst the early reports of the GTPase activity were
contested by another group (Gombos et al., 2001), more recent
reports suggest that the GTPase activity of calexcitin is
stimulated by calcium in several species, most notably
Drosophila (Nelson et al., 2003). Calcium ions are known
to bind to the protein with submicromolar afﬁnity and they
induce signiﬁcant conformational changes within the physio-
logical Ca2+ concentration range. This has been demonstrated
by circular dichroism (CD), ﬂuorescence, NMR and infrared
spectroscopy (Gombos et al., 2001; Ascoli et al., 1997).
Calexcitin shares signiﬁcant sequence identity (almost 40%)
with juvenile hormone diol kinase (JHDK), an insect enzyme
that uses ATP or GTP to phosphorylate its polyisoprene
substrate (Maxwell, Welsh, Horodyski et al., 2002; Maxwell,
Welch & Schooley, 2002; Li et al., 2005). Intriguingly, the
activity of JHDK is inhibited by the presence of calcium,
suggesting that the calcium-free or partly decalciﬁed form of
the protein may be the catalytically active species.
The three-dimensional structure of L. pealei calexcitin has
been determined by X-ray analysis at a resolution of 1.8 A˚
(Beaven et al., 2005; Erskine et al., 2006). The overall structure
is predominantly helical and compact, with a pronounced
hydrophobic core between the N- and C-terminal domains of
the molecule. The structure consists of four EF-hand motifs
(numbered 1–4 from the N-terminus to the C-terminus),
although only the ﬁrst three EF-hands are involved in binding
calcium ions since the C-terminal EF-hand (number 4) lacks
the amino acids required for calcium binding. The overall
structure is quite similar to that of the sarcoplasmic calcium-
binding protein from Amphioxus (ASCP), although the
sequence identity is low at 31% (Cook et al., 1993; Vijay-
Kumar & Cook, 1992). The structure showed that the two
amino acids of calexcitin which are known to be phosphory-
lated by protein kinase C are close to the domain interface and
thus phosphorylation is likely to regulate the opening of the
domains that is probably required for binding to target
proteins. The residues which have been implicated in the
GTPase activity of calexcitin by mutagenesis are in a short but
highly conserved region of 310-helix close to the C-terminus.
This helix resides in a large loop that is partly sandwiched
between the N- and C-terminal domains, suggesting that GTP
binding may also require or may cause domain opening. The
structure possesses a pronounced electropositive crevice in the
vicinity of the 310-helix that might provide an initial docking
site for the triphosphate group of GTP.
In this paper, we report a number of biophysical and
structural studies of site-directed mutants of calexcitin which
were designed to probe the role of its calcium-binding and
phosphorylation sites. An invariant feature of the EF-hand
motif is that one of the acidic amino acids which coordinate
the calcium ion does so using both of its carboxylate O atoms.
Mutation of the corresponding aspartate or glutamate residue
to an asparagine or glutamine, respectively, has been shown to
signiﬁcantly reduce the afﬁnity of the affected site for calcium
ions, effectively abolishing the site, with the minimum of
perturbation to the surrounding protein structure (Staro-
vasnik et al., 1991; Maune, Beckingham et al., 1992; Maune,
Klee et al., 2002; Martin et al., 1992). Accordingly, we have
engineered the mutations D34N, E85Q and E130Q which
affect the bidentate ligands in each of the three calcium-
binding sites of calexcitin, the ﬁrst two of which reside in the
N-terminal domain of the protein (sites 1 and 2) and the last in
research papers
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the C-terminal domain (site 3). The afﬁnity of each of these
mutants for Ca2+ ions has been measured by calcium-titration
experiments using tryptophan ﬂuorescence in order to discern
which of the sites is likely to have a calcium-sensory role in the
neuron. The sensory site would be expected to have an afﬁnity
just below the micromolar range, whereas the higher afﬁnity
calcium-binding sites have been shown to have an afﬁnity in
the nanomolar range. In vivo, calexcitin can be phosphorylated
by PKC at two positions (Thr61 and Thr188) and this is linked
to changes in its electrophysiological effects (Nelson & Alkon,
1995). Whilst O-linked phosphorylation of proteins can occur
at serine, threonine and tyrosine residues in eukaryotic cells,
Escherichia coli is unable to phosphorylate these amino acids.
For proteins which are expressed in E. coli, one common way
to mimic phosphorylation is to mutate the corresponding
residues to one of the negatively charged amino acids aspar-
tate or glutamate, which resemble the charge state of a
phosphorylated side chain. Accordingly, we have engineered
T61D and T188D mutations in calexcitin and repeated the
calcium-titration experiments to assess the effects of phos-
phorylation on the calcium-binding behaviour of the protein,
and have determined the crystal structures of these two
mutants as well as the corresponding double mutant. We have
also carried out pebble-game rigidity analysis and normal-
mode-biased geometric simulations on wild-type and mutant
structures in order to explore the constraint network, and the
capacity for ﬂexible motion, of calexcitin. Rigidity analysis
is advantageous in identifying the network of noncovalent
interactions in the protein and their effect in stabilizing and
constraining the crystal structure (Jacobs et al. 2001). In this
case we obtain particularly interesting results on the inter-
actions between the N-terminal and C-terminal domains.
Geometric simulations biased along low-frequency normal-
mode directions (Jimenez-Roldan et al., 2012) are a rapid and
efﬁcient method to explore the intrinsic ﬂexibility of a protein
crystal structure by generating variant structures with the
same local covalent and noncovalent bonding geometry as the
crystal. The results are useful both practically in reconciling
static and dynamic structural data and conceptually in visua-
lizing the protein as an intrinsically ﬂexible and dynamic
macromolecule rather than a ‘frozen’ crystal structure.
2. Materials and methods
2.1. Mutagenesis, expression and crystallization of mutant
calexcitins
Expression, nickel-afﬁnity puriﬁcation, crystallization and
structure determination of wild-type L. pealei calexcitin has
been described previously (Beaven et al., 2005; Erskine et al.,
2006). The QuikChange mutagenesis system (Agilent Tech-
nologies) was used to introduce the desired base changes into
the pET-16b calexcitin expression construct (a kind gift from
Professor Dan Alkon, Blanchette Rockefeller). The following
mutagenic primers were obtained from Integrated DNA
Technologies (Coralville, USA) for the EF-hand mutations
(D34N, E85Q and E130Q), where the ‘f’ and ‘r’ sufﬁxes
indicate the forward and reverse primers, respectively: D34Nf,
GGCGGGTCATTGAATGGGATAATTTTGAGCTGGCC;
D34Nr, GGCCAGCTCAAAATTATCCCATTCAATGAC-
GCC; E85Qf, GAGCAAGTTACTAAAGAGCAATGGCT-
GAAGATGTGGGCC; E85Qr, GGCCCACATCTTCAGCC-
TATGCTCTTTAGTAACTTGCTC; E130Qf, GGTGACAA-
CATTATTGACAAACATCAGTACAGTACTGTC; E130Qr,
GACAGTACTGTACTGATGTTTGTCAATAATGTTGTC-
ACC. The following primers were ordered from Eurogentec
(Liege, Belgium) for the phosphorylation-mimic mutations
(T61D and T188D): T61Df, GAGGCCAGAGCTGACC-
TGAAACTCATCTGGG; T61Dr, CCCAGATGAGTTTCA-
GGTCAGCTCTGGCCTC; T188Df, GGGGCTAAGGGC
AACCATCTGTTTGGTGACCTAAAACTTTAA; T188Dr,
TTAAAGTTTTAGGTCACCAAACAGATGGTTGCCCTT-
AGCCCC. Each mutagenesis reaction was undertaken using
a Techne Progene thermal cycler and each point mutation
was conﬁrmed by DNA sequencing (DNA Sequencing and
Services, Dundee, Scotland). All possible double mutants of
the metal-binding sites (D34N+E85Q, D34N+E130Q and
E85Q+E130Q) and the phosphorylation sites (T61D+T188D)
were engineered by repeating the above process on DNA
which had already been mutagenized once and were
conﬁrmed again by sequencing. The mutant DNA was trans-
formed into E. coli BL21(DE3) cells for expression in LB
medium. Cells were grown at 37C to mid-log phase in LB
medium with 50 mg ml1 ampicillin and were then induced by
the addition of isopropyl -d-1-thiogalactopyranoside (IPTG)
to a ﬁnal concentration of 1 mM and grown overnight at 37C.
In one case where the mutant protein was found in inclusion
bodies (E130Q), the expression was repeated as above except
that the cells were given a 30 min heat shock at 42C followed
by cooling for 5 min on ice prior to induction with IPTG and
growth at 16C for 2 d. The resulting cell cultures were
pelleted and lysed by sonication in a buffer consisting of
50 mM Tris pH 7.5, 100 mM NaCl, 1 mM CaCl2 prior to
ultracentrifugation at 40 000g for 40 min. The subsequent
puriﬁcation of the His-tagged protein from the supernatant
involved the use of HisTrap 1 ml nickel-afﬁnity columns (GE
Healthcare), from which the protein was eluted with 250 mM
imidazole. The afﬁnity-puriﬁed protein was then re-equili-
brated with the lysis buffer and concentrated to 3 mg ml1
using a Vivaspin centrifugal concentrator (GE Healthcare)
with a 10 kDa cutoff. Crystals of the T61D, T188D and
T61D+T188D mutant calexcitins were grown by the vapour-
diffusion method using the conditions reported for the wild-
type protein (Beaven et al., 2005). This involved mixing 5 ml
protein solution at a concentration of 3 mg ml1 with 5 ml
well solution consisting of 15–40%(w/v) PEG 4000, 100 mM
sodium citrate pH 5.5–7.0, 200 mM ammonium acetate. Large
crystals of up to 1 mm in their longest dimension appeared
within 2–3 weeks at room temperature. The crystals were
mounted in loops with approximately 30%(v/v) glycerol
added as a cryoprotectant and ﬂash-cooled in a nitrogen-gas
cryostream at 100 K. Data collection using a PILATUS
detector at station I04-1 of the Diamond synchrotron revealed
that the crystals were orthorhombic and belonged to space
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group P212121. Data processing withMOSFLM (Leslie, 2006),
SCALA (Evans, 2006) and other programs in the CCP4 suite
(Winn et al., 2011) yielded intensity data to high resolution
(for details, see Table 1). The crystals contained two calexcitin
monomers per crystallographic asymmetric unit. Since the
T61D mutant had the same unit-cell parameters as the
wild-type protein, the structure was reﬁned directly using
REFMAC (Murshudov et al., 2011). However, the T188D
mutant had an appreciably different unit cell and structure
analysis therefore proceeded by molecular replacement using
MOLREP (Vagin & Teplyakov, 2010) with a monomer of
the wild-type protein as the search model. Reﬁnement was
undertaken as for the other mutants, with introduction of the
mutant residue(s) and other manual rebuilding performed
using Coot (Emsley & Cowtan, 2004). The Rfree reﬂection set
was chosen using SHELXPRO (Sheldrick & Schneider, 1997)
in thin resolution shells to avoid bias between the working
and test sets owing to the presence of noncrystallographic
symmetry. Except for the initial round of reﬁnement, in which
rigid-body constraints were applied to both monomers in
the asymmetric unit, noncrystallographic symmetry (NCS)
restraints were not used. The reﬁnement statistics of the ﬁnal
model are shown in Table 1. Validation tests were performed
using PROCHECK (Laskowski et al., 1993), SFCHECK
(Vaguine et al., 1999) andMolProbity (Lovell et al., 2003; Chen
et al., 2010). Figures showing molecular structures were
prepared using CueMol (http://www.cuemol.org/en) and POV-
Ray (http://www.povray.org). The coordinates and structure
factors for the T61D, T188D and double mutant constructs
have been deposited in the Protein Data Bank and assigned
accession numbers 4ndb, 4ndc and 4ndd, respectively.
2.2. Calcium-titration experiments
Aliquots of the concentrated protein were dialysed against
a 2 l volume of 1 mM EGTA for 24 h to remove calcium ions
bound to the protein. After 24 h, the EGTA solution was
exchanged for 2 l deionized water and left for a further 24 h.
The decalciﬁed protein was then re-concentrated, as above, to
2 mg ml1. The calcium-binding afﬁnities of the mutants were
then determined using a ﬂuorescence-based calcium-titration
assay. A range of stock calcium solutions of precise molarity
were made by dissolving calcium carbonate in water by the
dropwise addition of 10M HCl. Similarly, a stock solution of
0.15M EGTA was made by the dropwise addition of 10M
NaOH to dissolve the chelating agent. For the ﬂuorescence
measurements, 10 ml decalciﬁed protein at 2 mg ml1 and
10 ml 0.15M EGTA were added to 980 ml 50 mM HEPES pH
7.5, 0.1M KCl in a quartz cuvette followed by mixing. The
ﬂuorescence spectrum was then recorded using an excitation
wavelength of 295 nm with a Shimadzu RF-500 IPC spectro-
ﬂuorometer and the ﬂuorescence emission intensity in the
wavelength range 305–400 nm was integrated. Following this,
2 ml volumes of each of the calcium stock solutions were added
to the cuvette prior to mixing and equilibration at 25C. At
each calcium ion concentration, the ﬂuorescence spectrum was
recorded as above. The total free concentration of calcium
ions for each measurement was calculated using MAX-
CHELATOR (Bers et al., 1994).
2.3. Circular-dichroism (CD) spectroscopic studies
The phosphorylation-mimic mutants and wild-type calex-
citin were transferred to 50 mM phosphate buffer pH 7.5 with
1 mM CaCl2 and 10 mM -mercaptoethanol present. CD
spectra were recorded using an Aviv 62DS instrument over a
wavelength range from 280 to 180 nm using a 1 nm interval
and a dwell time of 1 s at a temperature of 25C. Cylindrical
quartz Suprasil optical cells (Helma UK Ltd) with path lengths
of 0.0015, 0.0024 and 0.005 cm were used. In each case, three
replicate sample spectra were measured. Three replicate
baseline spectra (consisting of the buffer without protein)
were also obtained. The replicate sample spectra were aver-
aged and the averaged baseline spectrum was subtracted from
each of them. The subtracted spectra were calibrated against
the spectrum of camphorsulfonic acid (Miles et al., 2003) and
scaled to units of " using mean residue weights of 117.2 for
the wild type, 117.3 for the single mutants and 117.4 for the
double mutant. Processing was carried out using the CDtool
software (Lees et al., 2004) and secondary-structure analyses
were performed using the DichroWeb analysis server (Whit-
more & Wallace, 2008). The proportion of helix was deter-
mined as the average of values from the CONTINLL (Van
Stokkum et al., 1990), SELCON3 (Sreerama et al., 1999) and
CDDSTR (Sreerama & Woody, 2000) algorithms, which were
used with the SP175t reference data set (Lees et al., 2006). The
CD spectra and metadata have been deposited in the Protein
Circular Dichroism Data Bank (PCDDB) located at http://
research papers
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Table 1
X-ray crystallographic and data-processing statistics for the mutants of
calexcitin.
Values in parentheses are for the outer resolution shell.
Mutant T61D T188D T61D+T188D
Space group P212121 P212121 P212121
Unit-cell parameters
a (A˚) 47.2 46.0 46.8
b (A˚) 69.2 68.0 69.4
c (A˚) 135.4 125.9 133.5
Resolution (A˚) 27.9–2.0
(2.1–2.0)
28.2–2.0
(2.1–2.0)
46.8–2.9
(3.1–2.9)
Rmerge† (%) 7.7 (34.7) 10.4 (53.8) 9.4 (53.0)
Rmeas‡ (%) 8.4 (37.8) 11.4 (59.1) 10.7 (59.9)
CC1/2§ (%) 99.7 (93.4) 99.7 (76.9) 99.5 (78.5)
Completeness (%) 98.2 (98.2) 95.4 (94.4) 98.4 (99.5)
Average I/(I) 16.0 (5.2) 10.6 (3.1) 13.9 (3.9)
Multiplicity 6.5 (6.4) 6.1 (5.8) 4.6 (4.6)
Mosaicity () 0.3 1.0 0.8
R factor (%) 16.3 17.0 17.1
Rfree (%) 21.2 22.4 28.3
Total unique reﬂections 28737 24739 9359
R.m.s.d., bond lengths (A˚) 0.02 0.02 0.01
R.m.s.d. bond angles () 1.9 1.8 1.6
† Rmerge =
P
hkl
P
i jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ. ‡ Rmeas =
P
hklfNðhklÞ=
½NðhklÞ  1g1=2Pi jIiðhklÞ  hIðhklÞij=
P
hkl
P
i IiðhklÞ, where hI(hkl)i is the mean
intensity of the N(hkl) observations Ii(hkl) of each unique reﬂection hkl after
scaling. § CC1/2 is the half-set correlation coefﬁcient as described by Karplus &
Diederichs (2012).
electronic reprint
pcddb.cryst.bbk.ac.uk/home.php as entries CD0004676000 to
CD0004679000.
2.4. NMR studies
Uniformly labelled recombinant calexcitin was over-
expressed in E. coli BL21(DE3) cells grown solely on M9
medium supplemented with 1 g l1 15NH4Cl and 2 g l
1 13C6-
d-glucose. Prior to induction, the cultures were incubated at
37C before being cooled to 30C and subsequently incubated
with 1 mM IPTG for 18 h. The cells were harvested and the
labelled calexcitin was puriﬁed as described previously. NMR
samples were prepared as 1 mM calexcitin in 20 mM bis-tris,
50 mM KCl, 10 mM CaCl2, 1 mM dithiothreitol (DTT) pH 7
containing 0.05% NaN3 in 600 ml 5% D2O in H2O for
assignment purposes. Such samples were diluted with the
aforementioned buffer to half of the original calexcitin
concentration for relaxation and residual dipolar coupling
(RDC) measurements. Aligned samples were prepared by
adding a pre-dried 600 ml volume, 5 mm diameter, 5% poly-
acrylamide gel to a 600 ml 0.5 mM calexcitin sample and
allowing the gel to swell for 48 h at 4C prior to insertion into a
5 mm NMR tube and data collection.
All NMR experiments were performed on a Varian Inova
600 MHz spectrometer at 25C equipped with a room-
temperature 5 mm triple-resonance probe. Backbone assign-
ments of Ca2+–calexcitin were achieved using three-dimen-
sional HNCACB (Kay et al., 1994; Wittekind & Mueller, 1993)
and CBCACONH (Grzesiek & Bax, 1992) experiments. The
RDC data were used to investigate the solution structures of
the calexcitin domains and their relative orientations. NMR
data recorded on aligned samples revealed negligible chemical
shift changes when compared with the isotropic data, indi-
cating the effects of the gel matrix on the protein structure to
be minimal. [1H]–15N dipolar couplings were recorded from
0.5 mM calexcitin samples using two-dimensional IPAP-type
sensitivity-enhanced experiments (Ottiger et al., 1998) with an
acquisition time of 152 ms in the nitrogen dimension. The
errors in the RDCs were estimated to be 0.5 Hz. Alignment
tensors were calculated for each calexcitin domain (N-domain
including residues 2–100 and C-domain including residues
101–191) from [1H]–15N RDC data in secondary-structural
elements using the program Module. This allowed 32 and
36 RDCs to be resolved in the N-terminal and C-terminal
calexcitin domains, respectively, for the major conformer
excluding glycine and loop residues. The resulting alignment
tensors of the N-terminal and C-terminal domains were
rotated into a common coordinate frame by rigid-body
rotation of the C-terminal domain about Ser102. A minor
conformational state for calexcitin was treated the same way;
however, combining RDC measurements from the alternative
conformational state residues (that could be observed) with
those of the major conformer was deemed to be too unreliable
an approach since weak peaks from the minor conformer may
simply be masked by the major conformer and therefore the
resulting RDC set would be incorrect.
15N relaxation time constants were calculated from a series
of seven two-dimensional 15N T1 and T2 relaxation spectra
(Kay et al., 1992; Farrow et al., 1994) recorded with relaxation
delays of 0.02, 0.08, 0.16, 0.32, 0.6, 1.0 and 1.4 s and 0.01, 0.03,
0.05, 0.07, 0.09, 0.11 and 0.13 s for T1 and T2, respectively. The
data were processed with mild resolution enhancement and
zero-ﬁlling in the proton dimension and linear prediction in
nitrogen. All data were processed using NMRPipe and
NMRDraw (Delaglio et al., 1995) and were analyzed using
NMRview (Johnson & Blevins, 1994). Rotational correlation
times were calculated from the average T1:T2 ratio of residues
in secondary-structural elements only. Rotational correlation
time predictions using hydrodynamic modelling were made
directly from PDB structures or models with HYDRONMR
(Garcı´a de la Torre et al., 2000) using a temperature of 25C
and a bead size of 3.2 A˚.
Samples of calexcitin in the presence of GTP, GDPNP and a
synthetic pepide (Ac-LLPNTQSFPNC-NH2) mimicking part
of the ryanodine receptor which is reported to interact with
calexcitin (Nelson et al., 1999) were prepared at a ligand:
protein ratio of 20:1 with a calexcitin concentration of 0.1 mM
in the buffer deﬁned above. Chemical shift differences were
mapped from 15N HSQC spectra collected as described above.
2.5. Rigidity analysis and flexible motion simulations
Rigidity in calexcitin was explored using pebble-game
rigidity analysis as implemented in the software FIRST
(Jacobs et al., 2001), identifying polar and hydrophobic tether
interactions and dividing the structure into rigid clusters based
on the distribution of constraints and degrees of freedom. The
inclusion of polar interactions is controlled by an energy-
cutoff parameter ranging from 0 to 4 kcal mol1 to obtain
comparative information on the rigidity of different regions of
the protein. Manual removal of interdomain constraints, when
required, was achieved by editing the constraint lists used by
FIRST.
Flexible motion was explored using template-based
geometric simulation as implemented in the FRODA module
of FIRST (Wells et al., 2005). Motion was explored along low-
frequency normal-mode directions calculated using a coarse-
grained (one site per residue) representation of the protein
structure with the elastic network modelling software ElNe´mo
(Suhre & Sanejouand, 2004). In the construction of the elastic
network, springs of uniform strength were placed between all
-carbon positions lying within a 12 A˚ distance cutoff and
eigenvectors were obtained for the ten lowest frequency
nontrivial normal modes (modes 7–16, as modes 1–6 are trivial
rigid-body motions). Residues 1–5 in the N-terminus were
deleted from the structure, as otherwise multiple modes
localize on this relatively unstructured section of the molecule.
In the normal-mode biased geometric simulations (Jimenez-
Roldan et al., 2012), motion was explored parallel and anti-
parallel to each eigenvector using a directed step size of 0.01 A˚
for a total of 1000 steps in each trajectory, saving every 100th
step as a frame for analysis; this was sufﬁcient to project all
modes until their amplitude was limited by constraints in the
structure. The constraint network for ﬂexible motion included
polar interactions stronger than 3 kcal mol1.
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Simulations of a cleft-opening motion along the mode 7
direction were carried out with a constraint network edited to
remove interdomain noncovalent constraints. For this simu-
lation a smaller bias and a longer simulation trajectory were
used: a directed step size of 0.001 A˚ and a total of 100 000
steps, saving every 500th step as a frame for analysis.
3. Results
All possible single and double mutants of the bidentate ligand
residue at the three calcium-binding sites of L. pealei calex-
citin were engineered and expressed in E. coli. The single-site
mutants were expressed at high levels and were puriﬁed for
calcium-binding studies. However, out of the three double-site
mutants (sites 1 and 2, 1 and 3, and 2 and 3), only the mutant
with sites 1 and 2 altered (D34N+E85Q) could be expressed in
soluble form and this, too, could not be puriﬁed adequately for
calcium-binding studies. The other metal-site double mutants,
i.e. that affecting sites 1 and 3 and that affecting sites 2 and
3, both formed inclusion bodies and refolding was not
attempted. In contrast, the phosphorylation-mimic mutants
(T61D, T188D and T61D+T188D) could all be expressed in
high yield and crystallized for X-ray structure analysis.
3.1. Quality control of the structures
The crystal structures of the phosphorylation-mimic muta-
tions possess two molecules of calexcitin in the asymmetric
unit, with solvent contents of 44.8, 38.1 and 43.7% for the
T61D, T188D and T61D+T188D mutants, respectively. The
corresponding structural models for these three mutants,
which have been reﬁned using data to resolutions of 2.0, 2.0
and 2.9 A˚, have R factors of 16.3, 17.0 and 17.1%, with Rfree
values of 21.2, 22.4 and 28.3%, respectively (see Table 1). The
mutant structures superimpose closely with the best-deﬁned
moiety of the wild-type protein (Erskine et al., 2006), with low
r.m.s. deviations of 0.2, 0.4 and 0.4 A˚, respectively, for the
whole protein, and have reasonable mean isotropic tempera-
ture factors for all protein atoms of 17.6, 20.2 and 27.4 A˚2,
respectively. The ﬁnal structures have 98.7, 98.4 and 88.7% of
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Figure 1
The calcium-binding and phosphorylation sites of calexcitin. The tertiary
structure of calexcitin is shown with the helices as pink ribbons and the
strands coloured green. The three bound calcium ions are shown in pale
blue and the positions of the phosphorylated residues (Thr61 and Thr188)
within the protein fold are indicated in dark red. The hydrophobic core of
the protein is formed by a large number of aromatic residues which are
shown in a pale green ball-and-stick representation. The N-terminal
domain of the protein (at the bottom of the picture) essentially forms a
cup in which the upper C-terminal domain nestles. The 310-helix close to
the C-terminal end (helix 9) is shown towards the top right.
Figure 2
Electron-density maps (2.0 A˚ resolution) for the phosphorylation-mimic
mutations. (a) Asp61 of the T61D mutant structure and (b) Asp188 of the
T188D mutant. Whilst Asp61 is relatively devoid of interactions with the
surrounding protein, Asp188 is close to a salt bridge formed by Lys190
and Asp144. The A-weighted electron density shown in blue is
contoured at 1.0 r.m.s..
electronic reprint
their residues within the ‘favoured’ regions of the Rama-
chandran plot by theMolProbity criteria and all three have at
least 99% of their residues within the ‘allowed’ boundary. The
outlying residues are in regions with poor electron density
(at the extreme N-termini and C-termini) and hence their
conformations are poorly deﬁned. The isotropic temperature
factors for the protein moieties are reasonable except for a
few residues at the N-terminal and C-terminal ends of the
monomers, where the electron density for a small number of
residues remains poor despite extensive efforts to rebuild
them throughout the reﬁnement process.
3.2. Structural effects of the phosphorylation-mimic
mutations
Calexcitin adopts a compact conformation which is
dominated by -helical secondary-structure elements which
assemble to form a pronounced hydrophobic core involving a
striking number of closely packed aromatic residues. There
are four helix–loop–helix motifs that are formed by helices
1 and 2, 3 and 4, 5 and 6 and ﬁnally 7 and 8 which associate
together in pairs by antiparallel packing of their constituent
-helices (Fig. 1). The ﬁrst two helix–loop–helix motifs form
the N-terminal domain of the molecule (residues 2–101) and
the last two form the C-terminal domain (residues 102–191).
The ﬁrst three helix–loop–helix motifs of calexcitin (formed by
helices 1–6) adopt EF-hand folds and are involved in binding
calcium ions. In the C-terminal domain there is only one
functional metal-binding motif (formed by residues 119–130)
since the fourth helix–loop–helix motif lacks the key metal-
binding residues. The helices of the two helix–loop–helix
motifs in each domain are related by a topological twofold axis
which passes in between the Ca2+-binding loops. There are
parallels to the structure of calmodulin, a protein with four
functional EF-hands. The ﬁrst two and last two EF-hands of
calmodulin form distinct domains that can open upon calcium
binding, thereby creating a cleft which allows the molecule
to interact with target proteins (see, for example, Rhoads &
Friedberg, 1997).
Calexcitin is a substrate for protein kinase C (PKC) and
phosphorylation is associated with the translocation of
calexcitin to the cell membrane, where its effects on potassium
channels are exerted (Nelson et al., 1996). However, phos-
phorylation of calexcitin has been reported to inhibit its
interaction with the ryanodine receptor (Nelson et al., 1999).
Interestingly, the phosphorylation of peptides recognized by
calmodulin is known to prevent their binding to the protein
itself (Minakami et al., 1997; Nakajima et al., 1999). PKC acts
at consensus sequences of the form -(Ser/Thr)-X-(Arg/Lys)-,
and there is evidence that calexcitin is phosphorylated both at
Thr61, which lies in the sequence -Thr-Leu-Lys-, and at Thr188,
which lies four residues from the C-terminal end of the protein
in the same sequence (-Thr-Leu-Lys-; Gombos et al., 2001).
Accordingly, the X-ray structure shows that the side chains
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Figure 3
Fluorescence titration curves of the phosphorylation-mimic mutants. (a) The change in tryptophan ﬂuorescence as the demetallated protein is titrated
with calcium ions is shown for wild-type calexcitin; the titration curves of the T61D, T188D and T61D+T188D mutants are shown in (b), (c) and (d),
respectively.
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of Thr61 and Thr188 are exposed on the surface of the
molecule.
The CD spectra of the wild type and the phosphorylation-
mimic mutants were all very similar, and calculations
suggested they possess very similar secondary-structure
contents (see Supplementary Fig. S1). Indeed, all three
mutants crystallized under very similar conditions to native
calexcitin. The resulting electron-density maps for the Thr-to-
Asp mutants generally deﬁne the aspartate residues that are
introduced without any ambiguity in the main-chain or side-
chain conformation (Fig. 2). Superposition of both monomers
of the T61D mutant that are present in the asymmetric unit
with the corresponding monomers of the isomorphous wild-
type calexcitin structure revealed essentially no change in the
structure of the protein. The side chain of the aspartate
introduced by this mutation is clearly oriented in the same
direction as the side-chain hydroxyl group of the wild-type
threonine residue and does not appear to make any additional
interactions with the enzyme apart from hydrogen bonds to
surrounding water molecules
owing to its solvent-exposed
disposition. In contrast, the
mutation of Thr188 to aspartate
seems to introduce an additional
salt-bridge interaction with the
basic side chain two places along
the chain, namely Lys190, arising
from a conformational change in
this residue. In its new confor-
mation Lys190 can still retain the
ionic interaction that it makes
with Asp144 in the wild-type
structure. A hydrogen bond
formed by the side chain of the
wild-type Thr188 residue with the
main chain of Asp144 is lost in
the T188D mutant since the
newly introduced aspartate side
chain points in the opposite
direction. The T188D mutation
also introduces other local
changes in the structure such as a
conformational change in the side
chain of the hydrophobic residue
two places earlier in the chain,
namely Phe186. Indeed, in the
second monomer in the asym-
metric unit of this mutant struc-
ture the Asp188 residue is almost
completely disordered, an effect
which appears to cause the
Phe186 side chain to move
considerably and to induce
disorder in the neighbouring
buried side chain of Trp169.
Whilst the lower resolution of
the double-mutant structure
warrants some caution in interpretation of the ﬁndings, it is
clear that the effects observed in the two high-resolution
single-mutant structures are substantially replicated in the
corresponding double mutant. The most notable effects are
concentrated in the vicinity of the T188D mutation which, as
mentioned above, induces conformational changes in Trp169
and Asp186, as well as having an additional effect on Tyr110.
Very little change from the wild-type structure is seen in the
vicinity of the T61D mutation, which suggests that this is
unlikely to be the physiologically relevant phosphorylation
site. In contrast ‘phosphorylation’ of Thr188 is found to induce
local disruption of the adjacent hydrophobic residues in a
region of the molecule which is associated with its putative
GTPase activity and is at one of the major electropositive
openings into the hydrophobic interdomain cleft of the
protein. As a target residue for phosphorylation, it is inter-
esting that Thr188 resides very close to a region of 310-helix
which is formed by residues 181–185 since this is a type of
secondary
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Figure 4
The electrostatic effects of phosphorylation. The solvent-accessible surface of calexcitin showing the
electrostatic charge in the vicinity of (a) the T61D mutation and (b) the wild-type protein for comparison
and (c) the T188D mutation and (d) the same region of the wild-type protein. At physiological pH a
phosphate group will have an average charge between1 and2, which is greater than that of an aspartate
side chain.
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structure that is associated with low stability. A similar situa-
tion exists for the cyclin-dependent kinase inhibitors p21, p27
and p57, in which phosphorylation of a tyrosine residue within
a 310-helix disrupts the local fold and reduces the ability of the
protein to inhibit the associated kinase (Hashimoto et al.,
1998).
Fluorescence titration studies suggest that there are no
appreciable differences in the calcium-binding properties of
the T61D, T188D and T61D+T188D mutant proteins from
that of wild-type calexcitin (Fig. 3). This suggests that the
physiologically observed phosphorylation of calexcitin is
likely to affect the interactions with other proteins in the
signalling cascade rather than its metal-binding afﬁnity and
is fully in accord with the disposition of the respective sites
within the protein. The view shown in Fig. 1 demonstrates
that the calcium-binding sites are located at the poles of the
protein and the phosphorylation sites are within the equatorial
hollowed-out regions that are associated with domain
separation and binding to other proteins.
The surface of wild-type calexcitin has pronounced crevices
between the N- and C-terminal domains which lead into the
hydrophobic core of the molecule. Whilst the electrostatic
potential at the protein surface is dominated by acidic residues
forming the calcium-binding sites, there is a region of signiﬁ-
cant positive potential in the immediate vicinity of the
C-terminal 310-helix (helix 9). This arises from a number of
conserved basic residues, in particular Lys13 and Arg16, which
reside in helix 1 of calexcitin and interact with residues in the
310-helix. These residues form a positively charged groove
between the N-terminal and C-terminal domains that might
provide an initial docking site for the triphosphate group of a
GTP molecule.
A similar analysis of the phosphorylation-mimetic muta-
tions showed that these residue substitutions appear to
markedly alter the local electrostatic potential of the protein
in the vicinity of the cleft between the N-terminal and
C-terminal domains (Fig. 4). These mutations therefore confer
the interdomain groove with a more negatively charged
character, which could have implications for ligand binding,
although it should be stated that the electrostatics of the
protein are still very much dominated by the EF-hand motifs
even in the double T61D+T188D mutant. One of the inter-
esting effects of the T188D mutation is that it appears to
mask the basicity of His184, which lies within the C-terminal
310-helix. A strong electrostatic interaction between a phos-
phate group covalently added to Thr188 and the histidine
residue could disrupt the secondary structure of this short
helix. Accordingly, the structures demonstrate that the phos-
phorylation-mimetic mutation of Thr188 has a more disruptive
effect on the local protein structure than does the T61D
mutation.
3.3. Effects of the calcium-binding site mutations
Calcium-binding studies indicated that calexcitin binds 2–3
Ca2+ ions with two apparent dissociation constants: one in
the 107 M range and the other in the submillimolar range
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Figure 5
Fluorescence curves of the EF-hand mutants. The change in tryptophan ﬂuorescence as the demetallated protein is titrated with calcium ions is shown for
wild-type calexcitin in (a) with the titration curves of the D34N (site 1), E85Q (site 2) and E130Q (site 3) mutants shown in (b), (c) and (d), respectively.
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(Gombos et al., 2001; Ascoli et al., 1997). Whilst the highest
afﬁnity Ca2+ sites are quite likely to be fully occupied even
at the resting potential of the neuron, sites of near-millimolar
afﬁnity are likely to be regulatory sites or sensory sites that
would only be occupied during neuronal activation. Calcium
binding at a sensor site probably triggers a conformational
change, ultimately allowing calexcitin to bind to a target
molecule in a signalling pathway. Indeed, CD spectroscopy has
shown that calcium binding causes conformational changes
leading to an increase in the -helical content of the protein
(Ascoli et al., 1997). There are parallels to the structure of
calmodulin (a four EF-hand protein) in which the ﬁrst two and
last two EF-hands form distinct domains that separate when
calcium is bound, allowing interactions with target proteins.
Most commonly, a segment of the target protein binds in the
hydrophobic cleft between the N-terminal and C-terminal
domains of calmodulin as an -helix (Rhoads & Friedberg,
1997). It is worth noting that whilst calexcitin appears to form
a fairly closed structure in the crystal, many studies of
calmodulin have shown that it is more open and has a greater
degree of domain ﬂexibility.
Since the X-ray structure of wild-type calexcitin reveals
three well ordered calcium sites that appear to be fully
occupied by Ca2+ ions, this raises the question as to which of
these sites fulﬁll the sensory or regulatory role, as opposed
to simply providing a high-afﬁnity site that is occupied by
calcium regardless of the activation state of the neuron.
Consequently, we engineered and expressed a series of site-
directed mutants of calexcitin (D34N, E85Q and E130Q)
which abolish binding at each of the calcium sites (sites 1, 2
and 3, respectively).
The binding of calcium to wild-type and mutant calexcitin
was monitored using intrinsic tryptophan ﬂuorescence to
follow calcium binding to fully demetallated protein. The
resulting ﬂuorescence titration curves shown in Fig. 5 suggest
that mutation of either of the EF-hands in the N-terminal
domain (site 1 or 2) does not appreciably affect the calcium-
binding properties of the protein at either high or low calcium
concentrations. In contrast, mutation of the third EF-hand,
which resides in the C-terminal domain of the protein, appears
to abolish the lowest afﬁnity binding of calcium. This would
suggest that the third EF-hand (site 3) is the physiological
calcium-sensor site which allows the protein to respond to
changes in calcium-ion concentration during neuronal acti-
vation. The close association of the two EF-hands in the
N-terminal domain presumably allows them to associate very
tightly with calcium and therefore they are likely to be occu-
pied even when the neuron is in the resting state. In the
mutagenesis experiments, when either site 1 or 2 is mutated
the highly cooperative nature of the folding of this domain
may compensate for the lack of either one of the two calcium-
binding sites; hence, the tryptophan-ﬂuorescence changes that
are observed during the addition of calcium to demetallated
protein are substantially the same as the wild-type protein. In
contrast it is very likely that site 3 is the low-afﬁnity sensor site
owing to its lack of a partner calcium-binding loop within the
C-terminal domain.
3.4. NMR studies of calexcitin
Backbone assignment of calexcitin in solution immediately
revealed the presence of at least two species by the presence
of a distinct subset of resonances distributed throughout the
protein but most prominent around the ﬁrst calcium-binding
site between residues Thr20 and Lys40 (Fig. 6). The second
most populated conformer exists only as 10–20% of the total
protein present and does not seem to vary with calexcitin
concentration. From NMR signals exhibiting slow exchange in
HSQC spectra, we estimate exchange between these states to
be slower than 10 ms.
Residual dipolar couplings (RDCs) depend on the orien-
tation of individual bond vectors with respect to each other
and hence are very well suited to provide insight into the
domain orientation of proteins in solution. For the major
conformer of calexcitin, the NH RDCs were measured and
used to determine the alignment tensors of the N-terminal and
C-terminal domains individually using the X-ray structure as a
reference for both domains, where ,  and  represent the
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Figure 6
Assigned backbone amide NH NMR signals observed to exist in two states plotted against the calexcitin sequence. Not all signals from the minor
conformation are necessarily detected owing to peak overlap or intermediate exchange effects. Helical structure and calcium-coordinating residues are
highlighted.
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Euler angles of the three-dimensional coordinate axis of the
domain with respect to the frame of the X-ray coordinates
(PDB entry 2ccm; Erskine et al., 2006) and Aa and Ar repre-
sent the axial and rhombic components of the molecular
alignment tensor (Table 2). If the solution structure agrees
with the crystal structure, the orientations of the alignment
tensors of both domains would be expected to be the same.
While the angles  and  of both domains agree quite well, the
 angles differ by about 40. Accordingly, a model of the
solution structure was created in which the two domains of
calexcitin (N-domain, residues 2–101; C-domain, residues 102–
191) were rotated by 40 in order to satisfy the domain
alignment calculated from the RDC
data. This creates a more open structure
as illustrated by the superposition of the
N-terminal domains of the model and
the calexcitin crystal structure shown in
Figs. 7(a) and 7(b).
The dynamics of calexcitin were
investigated using NMR by measuring
the longitudinal (T1) and transverse (T2) relaxation times of
the backbone amide N atoms. A plot of T1 versus T2 (Fig. 8a)
reveals that most residues have similar relaxation times and
hence report similar rotational correlation times. This is
indicative of a well structured protein without signiﬁcant local
mobility on the subnanosecond timescale. Only residues at the
termini show additional fast internal motion as indicated by a
longer T2 (Fig. 8b). The N-terminal and C-terminal domains
tumble in solution with correlation times of 10.6 and 10.0 ns,
respectively, which are smaller than the 12.3 ns correlation
time predicted using HYDRONMR for calexcitin (PDB entry
2ccm) and the 14.3 ns correlation time predicted for the more
open RDC-derived model of the solution structure. Since the
experimental data yield a smaller correlation time than the
predictions from a rigid structure, we conclude that this is a
result of interdomain motion on a nanosecond timescale
(Rooney et al., 2004). Such motion reduces the T1 values and
consequently a number of residues show T1/T2 values outside
the theory-derived S2 = 1 curve. In addition, smaller than
calculated T2 values may reﬂect contributions to the line width
from aggregation effects. However, two residues, Trp169 and
Lys190, show clear signs of line broadening, i.e. small T2 values
that are indicative of motion on the microsecond–millisecond
time scale. Residues in calexcitin exhibiting two conforma-
tional states, weak peak intensity and/or short T2 have been
mapped to the structure in Fig. 9 and are coloured blue,
orange and green, respectively. Interestingly, the Trp169 side
chain was observed to adopt very different conformations in
Figure 7
Domain orientation of calexcitin in solution. (a) Superimposition of the N-terminal domain of the major conformer (orange) on the calexcitin crystal
structure (white, N-terminal domain; cyan, C-terminal domain) illustrating the rigid-body rotation that must be applied to the C-terminal domain in
order to satisfy the RDC data acquired for calexcitin in the solution state. (b) The same as in (a) but rotated through 90. (c) Plot of measured RDC
values versus those back-calculated from the solution-state model.
Table 2
Results of the alignment-tensor determination for calexcitin in solution.
Calexcitin domain  ()  ()  () Aa (104) Ar (104)
2 per
residue Q-factor
N-terminal domain 115.5  3.0 149.3  0.6 155.3  1 0 5.0  0.1 0.8  0.1 15.0  0.2 0.32
C-terminal domain 75.0  1.9 147.9  0.6 157.8  0.7 5.8  0.1 1.6  0.1 24.7  0.2 0.33
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the two molecules within the crystallographic asymmetric unit
in the original structural analysis of calexcitin (Erskine et al.,
2006).
Interactions of calexcitin with the peptide mimicking the
putative recognition site in the ryanodine receptor as well as
with GTP and the nonhydrolyzable analogue GDPNP were
investigated by titration up to a 20:1 maximum ratio of ligand
to protein. In both cases no signiﬁcant chemical shift changes
were observed in the 15N HSQC NMR spectra whether in the
presence or absence of exogenous calcium.
3.5. Rigidity in calexcitin: wild-type and T188D mutant
structures
We have examined the rigidity of the calexcitin structure
using pebble-game rigidity analysis (Jacobs et al., 2001), a
rapid integer algorithm for matching degrees of freedom
against constraints, using the freely available FIRST software
package. In this approach the constraint network includes
covalent and hydrophobic tether interactions, as well as a user-
controlled set of polar interactions. Potential hydrogen-bond
and salt-bridge interactions are assigned a bond energy based
on the donor–hydrogen–acceptor geometry; an energy cutoff
parameter Ecut then selects the interactions to include in the
constraint network. Comparison of the rigidity at different
values of Ecut provides information on the relative rigidity
(and hence, the potential ﬂexibility) of different regions of the
protein.
Figs. 10(a), 10(b), 10(c) and 10(d) shows the rigid cluster
decomposition of wild-type calexcitin at Ecut values of1,2,
3 and 4 kcal mol1, respectively. The overall behaviour of
the protein is typical for a largely -helical structure (Wells et
al., 2009). At small cutoff values the protein forms a single
large rigid cluster, while as the cutoff is lowered ﬂexibility
develops and rigidity is lost, ﬁrst from loop regions and then
from -helical regions. At large cutoff values the structure is
largely ﬂexible and only a few helices remain as separate rigid
clusters. It is notable that the C-terminal region, near the
phosphorylation site around residue 188 and the 310-helix, is
one of the ﬁrst portions of the structure to become ﬂexible,
consistent with the suggestion that rearrangements in this area
may occur and be signiﬁcant for function. The nearby ﬁrst
N-terminal helix, by contrast, is one of the most rigid regions
in the protein.
The T188D phosphorylation-mimic mutant structure has
comparable resolution to the wild-type structure and displays
some side-chain rearrangements in the area around the
mutation site, although the protein backbone geometry is very
similar to the wild-type structure. Figs. 10(e), 10( f), 10(g)
and 10(h) show the rigid cluster decomposition of T188D
calexcitin at Ecut values of 1, 2, 3 and 4 kcal mol1,
respectively, for comparison with the wild type. The mutant
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Figure 8
Backbone dynamics of calexcitin. (a) Parameterized plot of T1 versus T2
relaxation times with different order parameters S2 (green, S2 = 1; purple,
S2 = 0.9; grey, S2 = 0.8; brown, S2 = 0.7; yellow, S2 = 0.6; blue, S2 = 0.5)
using the Lipari–Szabo model-free approach. Measured T1 and T2
relaxation times for each backbone N atom in calexcitin are shown as
open rectangles. Residues in the N-terminal domain are in black and
those in the C-terminal domain are in red. (b) A plot of T2 relaxation
times versus calexcitin sequence. Calexcitin appears to be relatively rigid
with little fast internal motion. The dynamics are dominated by a slow
conformational exchange between two unequally populated states.
Figure 9
Overview of residues in calexcitin exhibiting two conformational states
(blue), weak peak intensity (orange) and short T2 (green). Each calcium
ion and the associated water molecule is shown as a dark-grey sphere.
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structure displays a decrease in rigidity compared with the
wild-type case, in the sense that groups of -helices forming a
single rigid cluster in the wild-type protein are separate rigid
clusters in the mutant structure; compare Figs. 10(b) and 10(c)
with Figs. 10( f) and 10(g) to observe this effect at Ecut values
of 2 and 3 kcal mol1. The increased ﬂexibility is not
localized to the mutation site but is observed across the
structure, as rigidity is not a purely local phenomenon.
3.6. Noncovalent interactions linking the N-terminal and
C-terminal domains
The NMR data indicate that in solution calexcitin exists not
only in the compact conformation observed in the crystal
structure but also in a more open state with the opening of a
large cleft separating the N-terminal and C-terminal domains.
It is therefore of interest to examine the set of noncovalent
constraints linking the two domains in the wild-type structure,
as it is this set which must be disrupted in the formation of the
more open structure.
Examination of the constraint network identiﬁed by FIRST
shows a relative paucity of noncovalent interactions linking
the two domains. The central part of the cleft between the
domains does not contain hydrophobic or strong polar inter-
actions. The interdomain interactions are instead found on
either side of the central cleft, particularly between the helices
closest to the linking region around residue 102. The non-
covalent interdomain contacts are mostly hydrophobic, with
only a few strong polar interactions. The noncovalent inter-
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Figure 10
Rigid clusters identiﬁed in calexcitin crystal structures by pebble-game rigidity analysis. The protein main chain is shown in stick representation with
large rigid clusters shown in cartoon form. Rigid clusters 1–20 are coloured in a spectrum from red to blue. (a), (b), (c) and (d): rigid clusters in wild-type
calexcitin, with constraint networks including polar interactions stronger than 1, 2, 3 and 4 kcal mol1, respectively. (e), ( f ), (g) and (h): rigid
clusters in T188D mutant calexcitin, with constraint networks including polar interactions stronger than1,2,3 and 4 kcal mol1, respectively. (i),
(j), (k) and (l): rigid clusters in wild-type calexcitin, excluding all interactions between N-terminal residues (up to residue 102) and C-terminal residues
(residues 103 onwards).
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actions are shown in Table 3 and Fig. 11. A small number of
residues, particularly Lys13, Val17, Phe21, Tyr172 and Trp90,
have a ‘keystone’ role in the constraint network, forming
interactions with multiple other residues, and these residues
are emphasized in Fig. 11. This brings out in particular the
strong, multiple hydrophobic tether links between the ﬁrst
N-terminal helix and the last C-terminal helices.
All of these interdomain interactions must be disrupted in
the formation of the more open structure. It is interesting to
note that the phosphorylation site at residue 61, which is not
itself directly involved in the interdomain constraint network,
lies close to a cluster of hydrophobic interactions linking the
domains. This suggests that an increase in the hydrophilicity at
this site, owing to the addition of the highly soluble charged
phosphate group, would favour the entry of solvent water
molecules into the interdomain cleft and the disruption of the
nearby hydrophobic tether network.
We examined the effect of disruption of the interdomain
noncovalent constraints by calculating the rigid cluster
decomposition of the wild-type calexcitin structure with the
interdomain constraints manually removed from the
constraint network. The results are shown in Figs. 10(i), 10(j),
10(k) and 10(l). The rigid clusters formed in this case are
almost identical to those formed in the wild-type structure
(compare Figs. 10a–10d). It thus appears that the interdomain
noncovalent constraints do not make a substantial contribu-
tion to the structural rigidity of the N-terminal and C-terminal
domains. This provides further justiﬁcation for the treatment
of calexcitin as a two-domain protein and is consistent with the
NMR data indicating that the N-terminal and C-terminal
domains remain individually well constrained but can separate
from each other by a cleft-opening motion in solution.
3.7. Normal-mode biased geometric simulations of flexible
motion in calexcitin
We have explored the capacity for ﬂexible motion of the
calexcitin structure using template-based geometric simula-
tions as implemented in the FRODA module (Wells et al.,
2005) of the FIRST software. This approach implements
motion in a fully detailed (all-atom) protein structure with a
simpliﬁed, localized physical model including the covalent
bonding geometry, steric exclusion and the noncovalent
interaction network identiﬁed by FIRST. Recent work in
methods development (Ahmed et al., 2011; Jimenez-Roldan et
al., 2012) has shown that it is particularly effective to explore
motion biased along low-frequency normal-mode eigen-
vectors. The combined use of FIRST/FRODA with the
ElNe´mo elastic network modelling software (Suhre & Sane-
jouand, 2004) has proved to be very successful as a generator
of structure-based hypotheses for data interpretation in
applications as diverse as protein–drug (calmodulin–cisplatin)
interactions (Li et al., 2012), large-scale domain reorientation
(Amin et al., 2013) and functional motion in citrate synthase
(Wells et al., 2014).
We have applied the FIRST/FRODA + ElNe´mo approach
(Jimenez-Roldan et al., 2012) to explore ﬂexible motion in
both the wild-type and T188D mutant calexcitin structures. In
each case eigenvectors were calculated for the ten lowest
frequency nontrivial normal modes. The eigenvectors thus
generated were very similar for the wild-type and mutant
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Table 3
Noncovalent interactions identiﬁed by FIRST between the N-terminal
and C-terminal domains in the wild-type calexcitin crystal structure.
Residues in bold are involved in noncovalent interactions with three or more
other residues. Multipliers (N) signify multiple interactions between the
given pair of residues.
Hydrophobic interactions Polar (hydrogen-bond) interactions
C-terminal
residue
N-terminal
residue
C-terminal
residue
N-terminal
residue
Energy
(kcal mol1)
Phe9 Leu191 Ser7 Asn176 0.780
Phe9 Arg178 Gln10 Val174 1.912
Lys13 Leu189 Lys13 Ser175 4.662
Lys13 Tyr172 Lys13 Glu171 0.229
Val17 Phe173 Lys13 Tyr172 (2) 2.285, 1.171
Val17 Tyr172 Lys13 Asn183 3.231
Val17 Phe186 Arg16 Tyr172 3.232
Phe21 Tyr138 (2) Arg16 Phe186 0.957
Phe21 Tyr135 (2) His46 Val117 4.277
Phe21 Phe186
Ile42 Phe113
Ala58 Phe113
Ile65 Lys109
Ile65 Tyr110 (2)
Leu69 Trp106
Tyr72 Pro104 (2)
Met89 Trp106
Trp90 Leu107 (2)
Trp90 Phe173 (3)
Cys93 Pro104
Val97 Val174
Val97 Leu103
Figure 11
Polar (purple) and hydrophobic (green) interactions between residues in
the N-terminal and C-terminal domains of wild-type calexcitin, as listed in
Table 3. The main chain is shown in transparent cartoon representation;
interacting residues are shown as thin sticks coloured light blue
(N-terminal residues) or light pink (C-terminal residues). Thicker stick
representation highlights residues involved in interdomain interactions
with three or more other residues (orange), residue Trp90 (yellow), which
makes multiple interactions with two C-terminal domain residues, and the
phosphorylation sites at residues 61 (blue, bottom of image) and 188 (red,
top of image).
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structures owing to the similarity of the backbone geometry.
Motion was explored with biases parallel and antiparallel to
each mode eigenvector, making a total of 20 trajectories for
each structure. All modes were explored to the limits of ‘easy
motion’ (Jimenez-Roldan et al., 2012), thus ﬁnding the
amplitudes at which ﬂexible motion becomes limited by the
steric and noncovalent constraints in the structure. Fig. 12
shows an overlay of 20 structures representing this envelope of
ﬂexible motion for the wild-type structure (Fig. 12a) and the
T188D phosphorylation mimic mutant (Fig. 12b). The mutant
structure was found to have a greater range of motion in the
C-terminal region around the mutation site. Interestingly, this
greater conformational freedom is transmitted to other parts
of the structure, including the ﬁrst N-terminal helix. These
results are consistent with the suggestion that phosphorylation
of residue 188 favours greater conformational freedom in the
region of the protein associated with putative GTPase activity.
On closer examination of the character of the lowest
frequency nontrivial normal-mode eigenvector (mode 7), it
appears that the mode includes some cleft-opening character;
that is, residues in the N-terminal domain on one side of the
interdomain cleft have components of motion oppositely
directed to those in the C-terminal domain on the other side of
the interdomain cleft. We have carried out simulations of
motion biased along this mode eigenvector with the inter-
domain noncovalent constraints eliminated. Fig. 13 shows an
overlay of a structure from the resulting trajectory with the
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Figure 12
Normal-mode dynamics in wild-type (a) and T188D mutant (b) calexcitin
structures. In each case the ribbon bundle shows the main-chain geometry
of conformers generated by geometric simulations which are biased
parallel and antiparallel to the ten lowest frequency nontrivial normal
modes (7–16) until the amplitude is limited by steric or noncovalent
interaction constraints. The chain is ‘rainbowed’ from blue (N-terminus)
to red (C-terminus). Simulations include residues 6–191; i.e. residues 1–5
were omitted as otherwise multiple modes localize on the N-terminal tail.
The T188D structure displays a slightly greater range of ﬂexible motion,
particularly around the C-terminal region (orange and red) and the
nearby N-terminal helix (dark blue).
Figure 13
Wild-type calexcitin structure projected by geometric simulation biased
along the lowest frequency nontrivial mode (mode 7) in the absence of
noncovalent constraints linking residues in the N-terminal and C-terminal
domains. The structure is projected from the starting state (semi-
transparent cartoon) to a much more open state comparable to that
identiﬁed by solution NMR (solid cartoon) by pivoting about the linker
region around residue 102. Structures are aligned on the N-terminal
domain to highlight the relative motion of the C-terminal domain as the
cleft opens.
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input wild-type structure. Motion along this mode in the
absence of interdomain constraints leads to substantial
opening of the cleft and a relative motion of the C-terminal
and N-terminal domains comparable in scale to that observed
in the NMR results.
4. Discussion
There are several reports that calexcitin is a calcium-activated
GTPase, although efforts to co-crystallize the protein with
GTP and nonhydrolyzable analogues have been unsuccessful,
as have extensive NMR studies of GTP binding. However,
mutagenesis studies have identiﬁed a number of residues that
appear to be important for the reported GTPase activity
(Nelson et al., 2003). These include Gly182, Phe186 and
Gly187 and a number of neighbouring amino acids that occur
in or are immediately adjacent to a region of 310-helix (helix 9)
at the C-terminus. This short helix is packed between helices 7
and 8 in the C-terminal domain and helix 1 in the N-terminal
domain (Fig. 1). The fact that helices 7 and 8 form the
nonfunctional EF-hand of the protein suggests that during
evolution the calcium-binding properties of this helix–loop–
helix motif may have been sacriﬁced to provide a GTP-binding
subdomain. The 310-helix occurs at the extremely hydrophobic
interface between the two domains of the protein which are
likely to separate upon binding of target molecules. Thus, it is
likely that calexcitin would also have to undergo a confor-
mational change in order to bind GTP. Interestingly, there is
clear evidence that this part of the buried interdomain core
has marked ﬂuidity, which is reﬂected in our observations
of the conformational disorder of certain side chains. The
proximity of site 3 to the putative GTP-binding region of the
protein, which includes the C-terminal 310-helix (residues 181–
185), might therefore allow the GTPase activity of calexcitin
to be regulated by calcium binding to the low-afﬁnity sensory
site of the protein. Interestingly, the homologous protein
juvenile hormone diol kinase, which uses GTP or ATP to
phosphorylate insect juvenile hormone, is inhibited by low
concentrations of calcium ions (Li et al., 2005).
Phosphorylation of calexcitin by PKC is reported to cause
its translocation to the cell membrane, where its effects on
potassium channels are exerted (Nelson et al., 1996). Calex-
citin has two PKC phosphorylation sites at positions Thr61
and Thr188. The ﬁrst of these, Thr61, is approximately in the
centre of helix 3 and is roughly equidistant from the second
and third calcium-binding sites (approximately 20 A˚). There
are no conserved basic residues in the vicinity of Thr61 that
might interact with a phosphate group, and the distance of this
residue from the calcium-binding sites suggests that phos-
phorylation may not affect their afﬁnity very much. However,
assuming that calexcitin interacts with target proteins in a
similar manner to calmodulin, the proximity of Thr61 to the
hydrophobic interface between the N-terminal and C-terminal
domains suggests that phosphorylation may alter both the
equilibrium between its open and closed forms and its afﬁnity
for target proteins. The proximity of the other phosphorylated
residue, Thr188, to the C-terminal end of the protein means
that it is also close to the interface between the N-terminal and
C-terminal domains, and thus phosphorylation of this residue
may also have an effect on domain opening. This residue is
close to a salt bridge formed between Asp144 and Lys190 and
is also close to His184 in the C-terminal 310-helix (helix 9) and
a number of other basic residues. Thus, phosphorylation of
Thr188 could have a signiﬁcant effect on the local conforma-
tion of the protein in a region that has been implicated in its
putative GTPase activity. This has indeed been conformed by
our structural studies, which showed marked local rearran-
gements of protein side chains in the vicinity of this phos-
phorylation-mimic mutation.
In the simulation studies, the presence of a cleft-opening
component in the lowest frequency nontrivial mode of motion
may be a reﬂection in the elastic network model of the protein
of the same phenomenon as observed in the constraint
network: a relative absence of interactions between the
N-terminal and C-terminal domains in the interior of the
interdomain cleft. Thus, our various computational investiga-
tions concur with the NMR results on this point that the
calexcitin structure, even though it seems to form a single
compact unit in the crystal structure, is in fact two separately
well constrained domains with a substantial capacity for
relative ﬂexible motion and the opening of an interdomain
cleft. The exposure of hydrophobic surfaces during cleft
opening would offer a route for calexcitin to interact with and
regulate other proteins in a manner similar to that observed
for calmodulin, which binds to other proteins through the
opening of methionine-rich hydrophobic clefts.
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